1. Home
  2. Browse Decisions
  3. F.Supp.2d
  4. 687 F.Supp.2d
  5. 687 F.Supp.2d 486 (2010)
 

GENETICS INSTITUTE v. NOVARTIS VACCINES & DIAG.

Civ. No. 08-290-SLR.

687 F.Supp.2d 486 (2010)

GENETICS INSTITUTE, LLC, Plaintiff, v. NOVARTIS VACCINES AND DIAGNOSTICS, INC., Defendant.

United States District Court, D. Delaware.

February 24, 2010.

Attorney(s) appearing for the Case

Jack B. Blumenfeld, Esquire and Karen Jacobs Louden, Esquire of Morris, Nichols, Arsht & Tunnell LLP, Wilmington, DE, for Plaintiff. Of Counsel: Barbara C. McCurdy, Esquire, Steven P. O'Connor, Esquire and Sanya Sukduang, Esquire of Finnegan, Henderson, Farabow, Garrett & Dunner, LLP, Washington, DC.

Richard K. Hermann, Esquire, Mary B. Matterer, Esquire and Amy Arnott Quinlan, Esquire of Morris James LLP, Wilmington, DE, for Defendant. Of Counsel: George A. Riley, Esquire, John C. Kappos, Esquire, and George C. Yu, Esquire of O'Melveny & Myers LLP, San Francisco, CA.

MEMORANDUM OPINION

SUE L. ROBINSON, District Judge.

I. INTRODUCTION

This is an action to determine priority of invention brought under 35 U.S.C. § 291. Plaintiff Genetics Institute, LLC ("GI" or "plaintiff") filed its complaint on May 16, 2008. In its complaint, plaintiff stated that it owns U.S. Patent No. 4,868, 112 ("the '112 patent"), entitled "Novel procoagulant proteins." Plaintiff seeks an adjudication of priority vis-a-vis two patents...

Let's get started

Leagle.com

Welcome to the leading source of independent legal reporting
Sign on now to see your case.
Or view more than 10 million decisions and orders.

  • Updated daily.
  • Uncompromising quality.
  • Complete, Accurate, Current.

Listed below are the cases that are cited in this Featured Case. Click the citation to see the full text of the cited case. Citations are also linked in the body of the Featured Case.

Cited Cases

  • No Cases Found

Listed below are those cases in which this Featured Case is cited. Click on the case name to see the full text of the citing case.

Citing Cases